Lumosa TherapeuticsLtd.
TWD66.50
0
-TWD2.00-2.92% 05:30 Today
Statistics
Day High
68.5
Day Low
66.5
52W High
222
52W Low
66.5
Volume
159,477
Avg. Volume
261,585
Mkt Cap
11.16B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 5Expected
Q4 2025
Q1 2026
Q2 2026
Next
-0.71
-0.58
-0.46
-0.34
Expected EPS
-0.39801803651999995
Actual EPS
N/A
Financials
15,995.63%Profit Margin
Profitable35.83MRevenue
5.73BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
Show More
CEO
Jung Chin Lin
Employees
36
Country
Taiwan
ISIN
TW0006535008
Listings
0 Comments
Share your thoughts
FAQs
What is Lumosa TherapeuticsLtd. stock price today?▼
The current price of 6535.TWO is TWD66.50 TWD — it has decreased by -2.92% in the past 24 hours. Watch Lumosa TherapeuticsLtd. stock price performance more closely on the chart.
What is Lumosa TherapeuticsLtd. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Lumosa TherapeuticsLtd. stocks are traded under the ticker 6535.TWO.
Is Lumosa TherapeuticsLtd. stock price growing?▼
6535.TWO stock has fallen by -6.6% compared to the previous week, the month change is a -21.76% fall, over the last year Lumosa TherapeuticsLtd. has showed a -68.56% decrease.
What is Lumosa TherapeuticsLtd. market cap?▼
Today Lumosa TherapeuticsLtd. has the market capitalization of 11.16B
When is the next Lumosa TherapeuticsLtd. earnings date?▼
Lumosa TherapeuticsLtd. is going to release the next earnings report on November 5, 2026.
What is Lumosa TherapeuticsLtd. revenue for the last year?▼
Lumosa TherapeuticsLtd. revenue for the last year amounts to 35.83M TWD.
What is Lumosa TherapeuticsLtd. net income for the last year?▼
6535.TWO net income for the last year is 5.73B TWD.
How many employees does Lumosa TherapeuticsLtd. have?▼
As of November 3, 2026, the company has 36 employees.
In which sector is Lumosa TherapeuticsLtd. located?▼
Lumosa TherapeuticsLtd. operates in the Health & Wellness sector.
When did Lumosa TherapeuticsLtd. complete a stock split?▼
Lumosa TherapeuticsLtd. has not had any recent stock splits.
Where is Lumosa TherapeuticsLtd. headquartered?▼
Lumosa TherapeuticsLtd. is headquartered in Taipei, Taiwan.